Dyne Therapeutics
Price & Volume
Stats
See moreOpen | $9.10 |
Previous Close | $8.91 |
Day Range | $8.25-$9.10 |
52W Range | $6.36-$47.45 |
Market Cap | $1.2B |
Shares Short | 16M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.61 |
News
See moreYahoo Finance • 2 days ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN
Yahoo Finance • 5 days ago
RBC Capital Maintains a Buy Rating on Dyne Therapeutics (DYN) With a $25 PT
Yahoo Finance • 14 days ago
Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
Yahoo Finance • 15 days ago
Stocks Settled Mixed as Higher Bond Yields Weigh on Sentiment
About
CEO | Mr. John G. Cox M.B.A. |
CFO | Mr. Erick J. Lucera C.F.A., C.P.A. |
Address | 1560 Trapelo Road, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 192 |
